These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 1429406
1. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ. J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406 [Abstract] [Full Text] [Related]
2. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine. Tollefson GD, Birkett M, Koran L, Genduso L. J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535 [Abstract] [Full Text] [Related]
8. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder. Sayyah M, Boostani H, Pakseresht S, Malayeri A. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):362-5. PubMed ID: 20035818 [Abstract] [Full Text] [Related]
11. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). Alaghband-Rad J, Hakimshooshtary M. Eur Child Adolesc Psychiatry; 2009 Mar 17; 18(3):131-5. PubMed ID: 19190958 [Abstract] [Full Text] [Related]
13. Predictors of drug treatment response in obsessive-compulsive disorder. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. J Clin Psychiatry; 1995 Aug 17; 56(8):368-73. PubMed ID: 7635854 [Abstract] [Full Text] [Related]
14. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report]. Wandzel L. Psychiatr Pol; 1997 Aug 17; 31(4):429-35. PubMed ID: 9527686 [Abstract] [Full Text] [Related]
15. The Children's Yale-Brown Obsessive-Compulsive Scale: item structure in an outpatient setting. McKay D, Piacentini J, Greisberg S, Graae F, Jaffer M, Miller J, Neziroglu F, Yaryura-Tobias JA. Psychol Assess; 2003 Dec 17; 15(4):578-81. PubMed ID: 14692851 [Abstract] [Full Text] [Related]
17. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Simeon JG, Thatte S, Wiggins D. Psychopharmacol Bull; 1990 Dec 17; 26(3):285-90. PubMed ID: 2274627 [Abstract] [Full Text] [Related]
18. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. Geller DA, Biederman J, Reed ED, Spencer T, Wilens TE. J Am Acad Child Adolesc Psychiatry; 1995 Jan 17; 34(1):36-44. PubMed ID: 7860454 [Abstract] [Full Text] [Related]
19. Citalopram treatment of children and adolescents with obsessive-compulsive disorder: a preliminary report. Mukaddes NM, Abali O, Kaynak N. Psychiatry Clin Neurosci; 2003 Aug 17; 57(4):405-8. PubMed ID: 12839522 [Abstract] [Full Text] [Related]
20. An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder administered in regular outpatient clinics. Valderhaug R, Larsson B, Götestam KG, Piacentini J. Behav Res Ther; 2007 Mar 17; 45(3):577-89. PubMed ID: 16836977 [Abstract] [Full Text] [Related] Page: [Next] [New Search]